Patients with Irritable Bowel Syndrome Exhibit Aberrant Expression of Endogenous Retroviruses and SETDB1
Cells · 2025
DOI: 10.3390/cells14030196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Pier-Angelo Tovo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy. Hauptthemen laut MEDLINE: Endogenous Retroviruses, Irritable Bowel Syndrome, Histone-Lysine N-Methyltransferase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CRT Foundation, the CRT Foundation, the University of Turin.
Abstract (Originalsprache)
Irritable bowel syndrome (IBS) is a common disease, whose etiopathogenesis is poorly understood. Human endogenous retroviruses (HERVs) originate from ancient infections of germinal cells and represent 8% of our DNA. Most HERVs have become defective due to the accumulated mutations; some can, however, still be activated, and their altered expressions have been associated with a number of chronic inflammatory and immune-mediated disorders, including gastrointestinal diseases. Retroviral transcription is modulated by TRIM28 and SETDB1, which also participate in the regulation of epigenetic mechanisms and in shaping the immune system. Expressions of HERVs and TRIM28/SETDB1 have not been investigated in patients affected by IBS. Using a PCR real-time Taqman amplification assay, we explored the RNA levels of HERV-H-pol, HERV-K-pol, and HERV-W-pol; syncytin 1 (SYN1), SYN2, and HERV-W-env; and TRIM28 and SETDB1 in the peripheral blood of 37 IBS patients and healthy controls (HCs) of similar age. The transcript levels were higher in IBS patients than in HCs for all HERVs except for HERV-W-pol, with significant p-values for HERV-H-pol, HERV-K-pol, and SYN1 and borderline p-values for SYN2 and HERV-W-env. The RNA levels of SETDB1 were significantly enhanced in IBS patients, while those of TRIM28 were in the normal range. Patients with severe disease had significant upregulation of SETDB1 compared to those with mild or moderate symptoms. These findings suggest that overexpression of HERVs and SETDB1 may contribute to the development of IBS and open the way to innovative therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
- Department of Medical Sciences, Division of Gastroenterology, University of Turin, 10123 Turin, Italy.
- Pediatric Laboratory, Department of Public Health and Pediatric Sciences, University of Turin, Regina Margherita Children's Hospital, Piazza Polonia 94, 10126 Turin, Italy.
ORCID-Profile: Gian Paolo Caviglia, Marta Guariglia, Ilaria Galliano, Massimiliano Bergallo
Förderung
- CRT Foundation
- the CRT Foundation
- the University of Turin
Zitieren
APA
Tovo, P. A., Ribaldone, D. G., Caviglia, G. P., Calvi, C., Montanari, P., Tizzani, M., Pitoni, D., Frara, S., Tribocco, E., Gambarino, S., Guariglia, M., Galliano, I., & Bergallo, M. (2025). Patients with Irritable Bowel Syndrome Exhibit Aberrant Expression of Endogenous Retroviruses and SETDB1. Cells. https://doi.org/10.3390/cells14030196
Vancouver
Tovo PA, Ribaldone DG, Caviglia GP, Calvi C, Montanari P, Tizzani M, et al. Patients with Irritable Bowel Syndrome Exhibit Aberrant Expression of Endogenous Retroviruses and SETDB1. Cells. 2025. doi:10.3390/cells14030196
BibTeX
@article{Tovo2025,
author = {Tovo, Pier-Angelo and Ribaldone, Davide Giuseppe and Caviglia, Gian Paolo and Calvi, Cristina and Montanari, Paola and Tizzani, Marco and Pitoni, Demis and Frara, Simone and Tribocco, Elisa and Gambarino, Stefano and Guariglia, Marta and Galliano, Ilaria and Bergallo, Massimiliano},
title = {Patients with Irritable Bowel Syndrome Exhibit Aberrant Expression of Endogenous Retroviruses and SETDB1},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14030196}
}
EUVIMED